- Home
- MURA vs OMH Comparison
MURA vs OMH Comparison
Compare MURA & OMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MURA
- OMH
- Stock Information
- Founded
- MURA 2013
- OMH 2015
- Country
- MURA Ireland
- OMH Singapore
- Employees
- MURA N/A
- OMH N/A
- Industry
- MURA
- OMH Real Estate
- Sector
- MURA
- OMH Finance
- Exchange
- MURA Nasdaq
- OMH Nasdaq
- Market Cap
- MURA 36.0M
- OMH 35.8M
- IPO Year
- MURA N/A
- OMH 2023
- Fundamental
- Price
- MURA $2.09
- OMH $1.24
- Analyst Decision
- MURA Buy
- OMH Hold
- Analyst Count
- MURA 2
- OMH 1
- Target Price
- MURA $6.00
- OMH N/A
- AVG Volume (30 Days)
- MURA 103.1K
- OMH 43.9K
- Earning Date
- MURA 11-04-2025
- OMH 10-30-2025
- Dividend Yield
- MURA N/A
- OMH N/A
- EPS Growth
- MURA N/A
- OMH N/A
- EPS
- MURA N/A
- OMH N/A
- Revenue
- MURA N/A
- OMH $7,976,578.00
- Revenue This Year
- MURA N/A
- OMH $28.40
- Revenue Next Year
- MURA N/A
- OMH $23.07
- P/E Ratio
- MURA N/A
- OMH N/A
- Revenue Growth
- MURA N/A
- OMH 117.53
- 52 Week Low
- MURA $0.95
- OMH $0.59
- 52 Week High
- MURA $4.74
- OMH $5.10
- Technical
- Relative Strength Index (RSI)
- MURA 52.55
- OMH 50.89
- Support Level
- MURA $2.06
- OMH $1.17
- Resistance Level
- MURA $2.10
- OMH $1.29
- Average True Range (ATR)
- MURA 0.01
- OMH 0.05
- MACD
- MURA 0.00
- OMH 0.01
- Stochastic Oscillator
- MURA 66.67
- OMH 65.00
About MURA Mural Oncology plc
Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.
About OMH Ohmyhome Limited
Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.